Participated · Series D · Sep 2015

Voalte develops smartphone applications that enable care teams inside and outside hospitals to access and exchange information securely. Founded in 2008 by CEO Trey Lauderdale and based in Sarasota, Florida, the company focuses on healthcare communication technology for clinical settings. Its solutions are used daily by over 50,000 caregivers at more than 150 healthcare organizations throughout the United States. Financially, Voalte has raised nearly $60 million in total funding to date. The company completed a $17 million Series D financing and intends to use the proceeds to continue to grow operations. No revenue figures were provided in the article. Voalte provides infrastructure that enables care teams to communicate inside and outside hospitals and to connect with existing and future technologies. Its flagship application, Voalte One, supports voice calls, delivers alarms and alerts to smartphones, enables secure text messaging, integrates with electronic medical record systems, and can act as a scanner for barcode medication administration. Voalte One is used by more than 35,000 caregivers at hospitals including Massachusetts General Hospital, Cedars-Sinai Medical Center, TIRR Memorial Hermann and Lurie Children’s Hospital. The company has about 130 employees. Management is led by co-founder and president Trey Lauderdale. Voalte plans to use new capital to accelerate market growth, expand the engineering team, and build out services and support.

Participated · Equity · Feb 2013

Sotera Wireless develops and sells ViSi Mobile, a body-worn, wireless vital-signs monitoring system designed for continuous 'monitoring in motion.' The platform captures all vital signs with the intent to keep clinicians connected to patients in bed, out of bed, or during transport. Sotera positions ViSi Mobile as a way to enable real-time monitoring of entire hospital populations and to address gaps where many U.S. hospital beds are not continuously monitored. The company intends to use recent financing proceeds to build out its sales network and channel distribution partners, accelerate commercialization and clinical development, and expand availability to hospitals across the United States. Management emphasizes the potential to reduce avoidable deaths, lower healthcare spending, and support complementary products built on Sotera’s proprietary technology. The company is headquartered in San Diego, California. Sotera Wireless, based in San Diego, has developed the ViSi Mobile System, a wearable platform designed to continuously monitor all vital signs and detect early signs of clinical deterioration. The company submitted its first 510(k) application for U.S. marketing clearance of the ViSi Mobile System to the U.S. Food and Drug Administration in August 2011, and that submission is under review. Leadership includes CEO Tom Watlington and President and CSO Matt Banet, Ph.D. Sotera plans to use new funding to support the global launch and commercialization of the ViSi Mobile System following regulatory clearance. The product positioning emphasizes continuous, multi‑vital monitoring for earlier detection of patient decline. The company completed a Series D financing to fund next steps toward commercialization. Sotera Wireless is a San Diego, CA–based medical device developer and supplier of a new generation of comprehensive vital-signs monitoring. Its core product is ViSi Mobile, a monitoring platform for continuous vital-signs surveillance. The company completed a $10.75M strategic financing to advance commercialization of ViSi Mobile. The round is described as a Series C and was led by West Family Holdings. Existing investors Sanderling Ventures, Qualcomm Ventures and Intel Capital also participated. The company said it will use the new funds to further efforts aimed at commercializing ViSi Mobile.